Novel Intranasal DHE Under Review for Migraine
INP104 uses proprietary technology to deliver a lower dose (1.45mg) of dihydroergotamine mesylate (DHE) to the upper nasal space.
Migraine and Headache
New Drugs Approved in 2020
Visit our New Drug Products page to stay up-to-date on the latest drug approvals.
NDA Submitted for Novel Intranasal DHE for Migraine
INP104 uses proprietary technology to deliver a lower dose (1.45mg) of dihydroergotamine mesylate (DHE) to the upper nasal space.
Erenumab Bests Topiramate in Head-to-Head Migraine Prevention Study
The HER-MES study included 777 adult patients suffering from at least 4 migraine days/month and who were naïve to, not suitable for, or had previously failed up to 3 prophylactic treatments.
Nerivio Device Cleared for Use in Patients With Chronic Migraine
Previously, the device had only been approved in those with episodic migraine.
FDA Rejects Qtrypta NDA for Acute Treatment of Migraine
Qtrypta delivers zolmitriptan, a selective 5-HT1B/1D receptor agonist, using the Company’s proprietary Adhesive Dermally-Applied Microarray (ADAM) technology that consists of a drug-coated microneedle patch.
Rimegepant Under Review for Migraine Prevention
The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for rimegepant (Nurtec™ ODT; Biohaven) for the preventive treatment of migraine. The sNDA is supported by data from a randomized, double-blind, placebo-controlled phase 2/3 study that assessed the efficacy and safety of rimegepant, a calcitonin gene-related peptide receptor antagonist,…
Cefaly Dual Migraine Treatment Now Available Over-the-Counter
Previously, the external trigeminal nerve stimulator was only available with a prescription.
Timolol Eyedrops Evaluated for Acute Migraine Treatment
During the study, 50 migraine patients randomly received either topically applied timolol maleate ophthalmic solution, 0.5%, or placebo eyedrops.
Botox Injections May Ease Depression
An FDA database revealed that people who receive Botox injections report less depression.
